DE60130253D1 - Zusammensetzungen zur verhinderung der adhäsion - Google Patents

Zusammensetzungen zur verhinderung der adhäsion

Info

Publication number
DE60130253D1
DE60130253D1 DE60130253T DE60130253T DE60130253D1 DE 60130253 D1 DE60130253 D1 DE 60130253D1 DE 60130253 T DE60130253 T DE 60130253T DE 60130253 T DE60130253 T DE 60130253T DE 60130253 D1 DE60130253 D1 DE 60130253D1
Authority
DE
Germany
Prior art keywords
compositions
preventing adhesion
administration
formulations
prevention
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60130253T
Other languages
English (en)
Inventor
Michael P Diamond
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Application granted granted Critical
Publication of DE60130253D1 publication Critical patent/DE60130253D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Sealing Material Composition (AREA)
  • Macromonomer-Based Addition Polymer (AREA)
DE60130253T 2000-11-21 2001-11-16 Zusammensetzungen zur verhinderung der adhäsion Expired - Lifetime DE60130253D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US25229700P 2000-11-21 2000-11-21
PCT/US2001/047362 WO2002041841A2 (en) 2000-11-21 2001-11-16 Compositions for adhesion prevention

Publications (1)

Publication Number Publication Date
DE60130253D1 true DE60130253D1 (de) 2007-10-11

Family

ID=22955426

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60130253T Expired - Lifetime DE60130253D1 (de) 2000-11-21 2001-11-16 Zusammensetzungen zur verhinderung der adhäsion

Country Status (7)

Country Link
US (1) US6518308B2 (de)
EP (1) EP1347754B1 (de)
AT (1) ATE371446T1 (de)
AU (1) AU2002236587A1 (de)
CA (1) CA2429624A1 (de)
DE (1) DE60130253D1 (de)
WO (1) WO2002041841A2 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7758654B2 (en) * 2004-05-20 2010-07-20 Kensey Nash Corporation Anti-adhesion device
AU2006268088B2 (en) * 2005-07-12 2011-05-12 Renovo Ltd Pharmaceutical compositions comprising a TGF-beta superfamily member
US20090269390A1 (en) * 2008-04-25 2009-10-29 Medtronic, Inc. Medical devices, polymers, compositions, and methods for delivering a haloacetate
US8507011B2 (en) 2009-03-23 2013-08-13 Robert D. Kross Method for suppressing or preventing fibrous adhesion formation using a multicomponent aqueous oxychlorine composition prepared on-site

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE456346B (sv) 1984-07-23 1988-09-26 Pharmacia Ab Gel for att forhindra adhesion mellan kroppsvevnader och sett for dess framstellning
US4819617A (en) 1986-09-04 1989-04-11 University Of Florida Viscoelastic material for ophthalmic surgery
WO1995024929A2 (en) 1994-03-15 1995-09-21 Brown University Research Foundation Polymeric gene delivery system
WO1997003702A1 (en) 1995-07-21 1997-02-06 Brown University Research Foundation A method for gene therapy using nucleic acid loaded polymeric microparticles
US6011017A (en) * 1998-04-15 2000-01-04 Cypros Pharmaceutical Corp. Method of reducing pulmonary hypertension and atrial fibrillation after surgery using cardiopulmonary bypass
EP1117835A4 (de) 1998-10-02 2005-03-09 Genzyme Corp Adhäsionsprävention
US6211217B1 (en) * 1999-03-16 2001-04-03 Novartis Ag Method for reducing pericardial fibrosis and adhesion formation
US6579889B2 (en) * 2000-06-22 2003-06-17 Merck & Co., Inc. Substituted isonipecotyl derivatives as inhibitors of cell adhesion

Also Published As

Publication number Publication date
US20020068762A1 (en) 2002-06-06
AU2002236587A1 (en) 2002-06-03
ATE371446T1 (de) 2007-09-15
EP1347754B1 (de) 2007-08-29
CA2429624A1 (en) 2002-05-30
EP1347754A2 (de) 2003-10-01
EP1347754A4 (de) 2004-10-13
WO2002041841A2 (en) 2002-05-30
US6518308B2 (en) 2003-02-11
WO2002041841A3 (en) 2002-10-31

Similar Documents

Publication Publication Date Title
DE60038183D1 (de) Verbindungen und zusammensetzungen zur abgabe aktiver wirkstoffe
DE60223254D1 (de) Verzögert freisetzende formulierungen von oxymorphon
ATE339406T1 (de) Chinazoline verbindungen als heilmittel
IL195723A (en) Use of p53 inhibitors for the preparation of medicament
ATE447947T1 (de) Pharmazeutische zubereitungen zur behandlung von insulinresitenz
ATE237330T1 (de) Verabreichung von nikotin im dickdarm zur behandlung von entzündlicher eingeweidenerkrankung
NO20062504L (no) Sammensetninger og doseringsformer for forbedret absorpsjon
DE60133555D1 (de) Verbindungen und gemische zur verabreichung eines aktiven agens
DE60324427D1 (de) Verfahren zur modulation der tubulindeacetylase-aktivität
CY1107465T1 (el) Μελαγατρανη για τη θepαπευτικη αντιμετωπιση φλεγμονων
AR032293A1 (es) Estuche farmaceutico
SE9900961D0 (sv) Novel compounds
DK1365808T3 (da) Sammensætninger til antitumorbehandling indeholdende ecteinascidin 743
SE9802208D0 (sv) Novel compounds
DK0998287T3 (da) Anvendelse af levobupivacain
GB9907571D0 (en) Compounds
EE05241B1 (et) Distamtsiini a-halogenoakrlolderivaadi kasutamine
NZ528164A (en) Use of flumazenil to produce a medicament for the treatment of cocaine dependency
SE9802209D0 (sv) Novel compounds
GEP201606538B (en) Preoperative treatment of post operative pain
ATE371446T1 (de) Zusammensetzungen zur verhinderung der adhäsion
EA200200853A1 (ru) Применение 2-метилтиазолидин-3,3-дикарбоновой кислоты (2-мтдк) и/или ее физиологически совместимых солей для лечения и/или предупреждения рака
FI20020197A0 (fi) Yhdistelmä akuutin myokardiilisen infarktin hoitoon
SE0004827D0 (sv) Therapeutic compounds
WO2001007029A3 (en) Substituted guanidines and the use thereof

Legal Events

Date Code Title Description
8332 No legal effect for de